robert bryant Very interesting, the dipyridamole clinical study but awGads it's small. Much sketchier even than the Raoult study of HCQ and Azi! Dipyridamole is sold as Persantine in the US, for use as an adjunct to anticoagulants in preventing clots in such things as artificial heart valves. Surprisingly, it seems to have a low incidence of adverse effects as per prescription information. The usual dose for the anticoagulant role is 200 mg of extended release twice a day or up to 400 mg of the rapid release three times a day (PLEASE! never take anything or decide on dose without advice of your physician!!!!!!). That makes it expensive. A bottle of 100 x 50 mg tablets at McGuff is $90 US for the generic. You don't want to know the cost of the brand product ($600+).
On the other hand, Montelukast (Singulair brand in the US) is very inexpensive. Less than $5 for 100 tabs from a medical supply house. It is used to treat bronchospasm and asthma (chronically, never for rescue) and seems pretty safe. You can Google prescribing information for dose and side effects and again: NEVER without advice from your physician.
Thanks for the info- every little bit helps. I only wish they had studied a larger group. The controls for the dipyridamole were only ten patients and they had wildly diverse outcomes.